From: Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C
Adverse effects
HCV genotype 1 (n = 15)
HCV genotype 3 (n = 22)
Cephalgia
8/15 (53.3%) *
8/22 (36.3%)
Fatigue
13/15 (86.6%) *
12/22 (54.5%)
Flu-like symptoms
10/15 (66.6%)
18/22 (81.8%) *